Free Trial

CG Oncology (CGON) Institutional Ownership

CG Oncology logo
$27.96 -0.71 (-2.48%)
(As of 02:09 PM ET)

Institutional Ownership Changes (13F Filings) for CG Oncology (NASDAQ:CGON)

Current
Institutional Ownership
Percentage
26.56%
Number of
Institutional Buyers
(last 12 months)
46
Total
Institutional Inflows
(last 12 months)
$848.15M
Number of
Institutional Sellers
(last 12 months)
11
Total
Institutional Outflows
(last 12 months)
$100.03M
Get CGON Insider Trade Alerts

Want to know when executives and insiders are buying or selling CG Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CGON Institutional Buying and Selling by Quarter

CG Oncology Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/27/2024 Franklin Resources Inc.1,230,193$46.16M0.0%+8.9%1.819%
11/18/2024 Neo Ivy Capital Management29,678$1.12M0.4%N/A0.044%
11/16/2024 Geode Capital Management LLC1,078,527$40.70M0.0%+96.2%1.608%
11/15/2024 M&T Bank Corp16,758$632K0.0%+55.7%0.025%
11/15/2024 Barclays PLC90,520$3.42M0.0%+331.1%0.134%
11/15/2024 Jane Street Group LLC195,951$7.39M0.0%+240.5%0.292%
11/15/2024 Wellington Management Group LLP510,219$19.25M0.0%+153.4%0.761%
11/15/2024 State Street Corp1,700,653$64.17M0.0%+73.0%2.535%
11/15/2024 Point72 Asset Management L.P.746,063$28.15M0.1%+575.7%1.112%
11/15/2024 Polar Asset Management Partners Inc.25,800$973K0.0%N/A0.038%
11/15/2024 Janus Henderson Group PLC1,526,534$57.60M0.0%+7.0%2.276%
11/15/2024 HighVista Strategies LLC15,734$594K0.2%N/A0.023%
11/15/2024 ArrowMark Colorado Holdings LLC230,390$8.69M0.1%+17.4%0.343%
11/14/2024 Braidwell LP3,170,875$119.64M3.4%-4.2%4.727%
11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC21,122$797K0.0%-10.6%0.031%
11/14/2024 Ally Bridge Group NY LLC263,266$9.93M5.3%+50.5%0.392%
11/14/2024 Zurcher Kantonalbank Zurich Cantonalbank6,399$241K0.0%N/A0.010%
11/14/2024 Yu Fan163,456$6.17M19.0%-89.6%0.244%
11/14/2024 ABG WTT Global Life Science Capital Partners GP Ltd495,526$18.70M92.9%-45.9%0.739%
11/14/2024 MetLife Investment Management LLC27,132$1.02M0.0%+103.2%0.040%
11/13/2024 BNP Paribas Financial Markets26,660$1.01M0.0%+876.9%0.040%
11/13/2024 FMR LLC145,606$5.49M0.0%+83,581.6%0.217%
11/13/2024 The Manufacturers Life Insurance Company73,149$2.76M0.0%+21.3%0.109%
11/12/2024 Charles Schwab Investment Management Inc.379,664$14.33M0.0%+114.0%0.566%
11/12/2024 Massachusetts Financial Services Co. MA279,945$10.56M0.0%+4.9%0.417%
11/4/2024 Los Angeles Capital Management LLC22,052$832K0.0%N/A0.033%
11/4/2024 TimesSquare Capital Management LLC437,069$16.49M0.2%+27.4%0.652%
10/30/2024 Amalgamated Bank1,621$61K0.0%+107.6%0.002%
10/3/2024 SG Americas Securities LLC17,595$664K0.0%N/A0.026%
9/16/2024 Point72 Asia Singapore Pte. Ltd.1,209$38K0.0%-75.5%0.002%
8/19/2024 Point72 Asset Management L.P.110,410$3.49M0.0%-40.7%0.166%
8/16/2024 Perceptive Advisors LLC733,695$23.16M0.6%-43.7%1.101%
8/16/2024 Driehaus Capital Management LLC106,951$3.38M0.0%-0.9%0.160%
8/15/2024 Scientech Research LLC8,803$278K0.1%-27.8%0.013%
8/15/2024 The Manufacturers Life Insurance Company60,301$1.90M0.0%-5.4%0.090%
8/15/2024 Deerfield Management Company L.P. Series C433,540$13.69M0.2%+811.9%0.651%
8/15/2024 Point72 Asia Singapore Pte. Ltd.1,209$38K0.0%-75.5%0.002%
8/14/2024 Marshall Wace LLP75,982$2.40M0.0%N/A0.114%
8/14/2024 Yu Fan1,578,344$49.83M65.1%N/A2.368%
8/14/2024 Ally Bridge Group NY LLC174,876$5.52M3.3%-45.4%0.262%
Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Register For The Webinar To Discover
8/14/2024 Profund Advisors LLC9,513$300K0.0%N/A0.014%
8/13/2024 Ensign Peak Advisors Inc60,565$1.91M0.0%N/A0.091%
8/9/2024 Renaissance Technologies LLC43,200$1.36M0.0%+204.2%0.065%
8/9/2024 Massachusetts Financial Services Co. MA266,787$8.42M0.0%+2.7%0.400%
8/3/2024 TD Asset Management Inc93,084$2.94M0.0%N/A0.140%
8/1/2024 Rhumbline Advisers34,229$1.08M0.0%+13.0%0.051%
7/26/2024 Bank of New York Mellon Corp89,344$2.82M0.0%+38.4%0.134%
5/17/2024 RA Capital Management L.P.1,397,433$61.35M0.8%N/A2.097%
5/16/2024 California State Teachers Retirement System2,341$103K0.0%N/A0.004%
5/16/2024 Janus Henderson Group PLC1,521,432$66.76M0.0%N/A2.283%
5/16/2024 BVF Inc. IL1,884,191$82.72M2.3%N/A2.827%
5/16/2024 Blackstone Inc.25,000$1.10M0.0%N/A0.038%
5/15/2024 Price T Rowe Associates Inc. MD992,118$43.56M0.0%N/A1.489%
5/15/2024 Avoro Capital Advisors LLC700,000$30.73M0.4%N/A1.050%
5/14/2024 StemPoint Capital LP40,723$1.79M0.5%N/A0.061%
5/14/2024 Decheng Capital LLC5,458,810$239.64M32.1%N/A8.191%
5/14/2024 American International Group Inc.306,226$13.44M0.0%N/A0.460%
5/13/2024 Ameritas Investment Partners Inc.2,320$102K0.0%N/A0.003%
5/10/2024 Vanguard Group Inc.2,225,018$97.68M0.0%N/A3.339%
5/7/2024 TimesSquare Capital Management LLC224,073$9.84M0.1%N/A0.336%
5/1/2024 Capstone Investment Advisors LLC18,354$806K0.0%N/A0.028%
5/1/2024 BNP Paribas Financial Markets11,198$492K0.0%N/A0.017%
(Data available from 1/1/2016 forward)

CGON Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CGON shares?

During the previous two years, 53 institutional investors and hedge funds held shares of CG Oncology. The most heavily invested institutionals were Decheng Capital LLC ($239.64M), Braidwell LP ($119.64M), Vanguard Group Inc. ($97.68M), BVF Inc. IL ($82.72M), State Street Corp ($64.17M), RA Capital Management L.P. ($61.35M), and Janus Henderson Group PLC ($57.60M).Learn more on CGON's institutional investors.

What percentage of CG Oncology stock is owned by institutional investors?

26.56% of CG Oncology stock is owned by institutional investors. Learn more on CGON's institutional investor holdings.

Which institutional investors have been buying CG Oncology stock?

Of the 46 institutional investors that purchased CG Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Decheng Capital LLC ($5.46M), Vanguard Group Inc. ($2.23M), BVF Inc. IL ($1.88M), Janus Henderson Group PLC ($1.62M), Yu Fan ($1.58M), RA Capital Management L.P. ($1.40M), and Price T Rowe Associates Inc. MD ($992.12K).

How much institutional buying is happening at CG Oncology?

Institutional investors have bought a total of 20,427,923 shares in the last 24 months. This purchase volume represents approximately $848.15M in transactions.

Which CG Oncology major shareholders have been selling company stock?

Of the 11 institutional investors that sold CG Oncology stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Yu Fan ($1.41M), Perceptive Advisors LLC ($570.41K), ABG WTT Global Life Science Capital Partners GP Ltd ($419.98K), Ally Bridge Group NY LLC ($145.50K), Braidwell LP ($138.63K), Point72 Asset Management L.P. ($75.83K), and Point72 Asia Singapore Pte. Ltd. ($7.45K).

How much institutional selling is happening at CG Oncology?

Institutional investors have sold a total of 2,783,055 shares in the last 24 months. This volume of shares sold represents approximately $100.03M in transactions.



This page (NASDAQ:CGON) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners